Australia's Opyl jumps on expanded dataset for AI platform

** Shares of Opyl OOPL rise as much as 56.3% to A$0.025, their biggest intraday gain since Sept. 3, 2020

** Artificial intelligence-based medical research co says its AI-driven clinical trial prediction and design optimisation platform TrialKey has expanded its dataset

** Says platform now provides insights based on over 350,000 trials, up from 65,000 trials previously

** Over 3.6 mln shares change hands, compared with the 30-day average volume of about 300,000

** Stock down 42.9% YTD based on last close